These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27621622)

  • 41. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular characterization and hormonal regulation of tissue inhibitor of metalloproteinase 1 in goat ovarian granulosa cells.
    Peng JY; Han P; Xin HY; Ji SY; Gao KX; An XP; Cao BY
    Domest Anim Endocrinol; 2015 Jul; 52():1-10. PubMed ID: 25700266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construction, gene delivery, and expression of DNA tethered nanoparticles.
    Prow T; Smith JN; Grebe R; Salazar JH; Wang N; Kotov N; Lutty G; Leary J
    Mol Vis; 2006 May; 12():606-15. PubMed ID: 16760897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder.
    Ramos FM; Delgado-Vélez M; Ortiz ÁL; Báez-Pagán CA; Quesada O; Lasalde-Dominicci JA
    J Neurovirol; 2016 Jun; 22(3):327-35. PubMed ID: 26567012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advancements in nano-enabled therapeutics for neuroHIV management.
    Kaushik A; Jayant RD; Nair M
    Int J Nanomedicine; 2016; 11():4317-25. PubMed ID: 27621624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Directing the Antiretroviral Drugs to the Brain Reservoir: A Nanoformulation Approach for NeuroAIDS.
    Nabi B; Rehman S; Pottoo FH; Baboota S; Ali J
    Curr Drug Metab; 2021; 22(4):280-286. PubMed ID: 32964821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy.
    Montoya JL; Iudicello J; Oppenheim HA; Fazeli PL; Potter M; Ma Q; Mills PJ; Ellis RJ; Grant I; Letendre SL; Moore DJ;
    AIDS; 2017 Mar; 31(6):787-795. PubMed ID: 28099190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection.
    Mukhtar M; Pomerantz RJ
    J Hum Virol; 2000; 3(6):324-34. PubMed ID: 11100913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel Acylguanidine-Based Inhibitor of HIV-1.
    Mwimanzi P; Tietjen I; Miller SC; Shahid A; Cobarrubias K; Kinloch NN; Baraki B; Richard J; Finzi A; Fedida D; Brumme ZL; Brockman MA
    J Virol; 2016 Oct; 90(20):9495-508. PubMed ID: 27512074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection.
    Ronaldson PT; Persidsky Y; Bendayan R
    Glia; 2008 Dec; 56(16):1711-35. PubMed ID: 18649402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.
    Crowell CS; Malee KM; Yogev R; Muller WJ
    Rev Med Virol; 2014 Sep; 24(5):316-31. PubMed ID: 24806816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice.
    Fiandra L; Colombo M; Mazzucchelli S; Truffi M; Santini B; Allevi R; Nebuloni M; Capetti A; Rizzardini G; Prosperi D; Corsi F
    Nanomedicine; 2015 Aug; 11(6):1387-97. PubMed ID: 25839392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier.
    András IE; Toborek M
    IUBMB Life; 2013 Jan; 65(1):43-9. PubMed ID: 23225609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanodelivery of antiretroviral drugs to nervous tissues.
    Lawal SK; Olojede SO; Faborode OS; Aladeyelu OS; Matshipi MN; Sulaiman SO; Naidu ECS; Rennie CO; Azu OO
    Front Pharmacol; 2022; 13():1025160. PubMed ID: 36425574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine.
    Roy U; Atluri VS; Agudelo M; Yndart A; Huang Z; Nair M
    Front Microbiol; 2015; 6():749. PubMed ID: 26284039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood-brain barrier properties of human immunodeficiency virus antiretrovirals.
    Yazdanian M
    J Pharm Sci; 1999 Oct; 88(10):950-4. PubMed ID: 10514337
    [No Abstract]   [Full Text] [Related]  

  • 58. HIV Associated Neurocognitive Disorders.
    Zhou L; Saksena NK
    Infect Dis Rep; 2013 Jun; 5(Suppl 1):e8. PubMed ID: 24470972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laser-enabled delivery of antiretroviral drugs into HIV-1 infected TZM-bl cells.
    Maphanga C; Manoto S; Mabena C; Ombinda-Lemboumba S; Maaza M; Mthunzi-Kufa P
    J Biophotonics; 2022 Oct; 15(10):e202200043. PubMed ID: 35852044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiretroviral drugs and the central nervous system.
    Enting RH; Hoetelmans RM; Lange JM; Burger DM; Beijnen JH; Portegies P
    AIDS; 1998 Oct; 12(15):1941-55. PubMed ID: 9814862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.